IL140729A0 - Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof - Google Patents
Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereofInfo
- Publication number
- IL140729A0 IL140729A0 IL14072999A IL14072999A IL140729A0 IL 140729 A0 IL140729 A0 IL 140729A0 IL 14072999 A IL14072999 A IL 14072999A IL 14072999 A IL14072999 A IL 14072999A IL 140729 A0 IL140729 A0 IL 140729A0
- Authority
- IL
- Israel
- Prior art keywords
- angiostatin
- processes
- preparation
- pharmaceutical compositions
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9283198P | 1998-07-14 | 1998-07-14 | |
PCT/US1999/015271 WO2000003726A1 (en) | 1998-07-14 | 1999-07-07 | Lysine binding fragments of angiostatin |
Publications (1)
Publication Number | Publication Date |
---|---|
IL140729A0 true IL140729A0 (en) | 2002-02-10 |
Family
ID=22235371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14072999A IL140729A0 (en) | 1998-07-14 | 1999-07-07 | Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof |
Country Status (7)
Country | Link |
---|---|
US (1) | US6538103B1 (xx) |
EP (1) | EP1096945A4 (xx) |
JP (1) | JP2002520367A (xx) |
AU (1) | AU751283B2 (xx) |
CA (1) | CA2337231A1 (xx) |
IL (1) | IL140729A0 (xx) |
WO (1) | WO2000003726A1 (xx) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6521424B2 (en) * | 1999-06-07 | 2003-02-18 | Immunex Corporation | Recombinant expression of Tek antagonists |
CA2368681A1 (en) * | 2000-02-10 | 2001-08-16 | Zymogenetics, Inc. | Anti-angiogenic intestinal peptides, zdint5 |
IT1317001B1 (it) * | 2000-03-13 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi. |
IT1317000B1 (it) * | 2000-03-13 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso di composti di origine naturale ad attivita' antiangiogenica. |
EP1320545A2 (en) | 2000-09-05 | 2003-06-25 | Karolinska Innovations AB | Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
GB0029001D0 (en) * | 2000-11-28 | 2001-01-10 | Isis Innovation | Assay |
NZ549787A (en) | 2004-03-12 | 2010-05-28 | Vasgene Therapeutics Inc | Antibodies binding to EphB4 for inhibiting angiogenesis and tumor growth |
US8034913B2 (en) | 2004-04-22 | 2011-10-11 | Grifols Therapeutics Inc. | Recombinantly modified plasmin |
US7973134B2 (en) * | 2004-07-07 | 2011-07-05 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways |
WO2006034455A2 (en) | 2004-09-23 | 2006-03-30 | Vasgene Therapeutics, Inc. | Polipeptide compounds for inhibiting angiogenesis and tumor growth |
US7935790B2 (en) * | 2004-10-04 | 2011-05-03 | Cell Singaling Technology, Inc. | Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways |
US20080119367A1 (en) * | 2004-12-17 | 2008-05-22 | Mayo Foundation For Medical Education And Research | Prognosis of Renal Cell Carcinoma |
US7807789B2 (en) * | 2004-12-21 | 2010-10-05 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in EGFR-signaling pathways |
US20090099340A1 (en) * | 2007-10-12 | 2009-04-16 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
WO2007027906A2 (en) * | 2005-08-31 | 2007-03-08 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
US20100151495A9 (en) * | 2005-08-31 | 2010-06-17 | Cell Signaling Technolgy, Inc. | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
US20070134231A1 (en) * | 2005-12-13 | 2007-06-14 | Jani Dharmendra M | Method for prolonging activity of autodegradable enzymes and compositions thereof |
DK2463305T3 (en) | 2006-01-12 | 2016-08-29 | Alexion Pharma Inc | Antibodies to OX-2 / CD200 and uses thereof |
WO2007127335A2 (en) * | 2006-04-27 | 2007-11-08 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways |
US7939636B2 (en) * | 2006-08-11 | 2011-05-10 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in c-Src signaling pathways |
US20090258442A1 (en) * | 2006-08-31 | 2009-10-15 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
CA2677007A1 (en) | 2007-02-01 | 2008-08-07 | Acceleron Pharma Inc. | Activin-actriia antagonists and uses for treating or preventing breast cancer |
US20090081659A1 (en) | 2007-03-07 | 2009-03-26 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
EP1975184A3 (en) | 2007-03-26 | 2008-11-26 | Cell Signaling Technology, Inc. | Serine or threonine phosphorylation sites |
US20080238709A1 (en) * | 2007-03-28 | 2008-10-02 | Faramarz Vaziri | One-way communication apparatus with dynamic key generation |
EP2145902A3 (en) | 2007-04-19 | 2010-09-29 | Peter Hornbeck | Tyrosine phosphorylation sites and antibodies specific for them |
US7977462B2 (en) | 2007-04-19 | 2011-07-12 | Cell Signaling Technology, Inc. | Tyrosine phosphorylation sites |
EP1983003A3 (en) | 2007-04-19 | 2009-03-11 | Peter Hornbeck | Tyrosine phosphorylation sites and antibodies specific for them |
US20090053831A1 (en) | 2007-05-01 | 2009-02-26 | Cell Signaling Technology, Inc. | Tyrosine phosphorylation sites |
US7960343B2 (en) | 2007-09-18 | 2011-06-14 | Acceleron Pharma Inc. | Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion |
US20090203043A1 (en) | 2007-11-21 | 2009-08-13 | Peter Hornbeck | Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways |
NZ585715A (en) * | 2007-11-29 | 2011-11-25 | Talecris Biotherapeutics Inc | Recombinantly modified plasmin |
US20090220991A1 (en) * | 2008-02-29 | 2009-09-03 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
AU2009256168B2 (en) * | 2008-06-04 | 2014-06-05 | Grifols Therapeutics Inc. | Composition, method and kit for preparing plasmin |
DE202008013741U1 (de) * | 2008-10-16 | 2010-03-25 | Mensing, Joachim, Dr., Miami Beach | Fluidspender und Fluidspendersystem |
US9206410B2 (en) | 2009-03-03 | 2015-12-08 | Grifols Therapeutics Inc. | Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom |
CN104411332B (zh) | 2012-03-30 | 2018-11-23 | 索伦托治疗有限公司 | 与vegfr2结合的全人抗体 |
EP4026849A1 (en) | 2016-09-26 | 2022-07-13 | Ensemble Group Holdings | Methods of assessing and treating cancer in subjects having dysregulated lymphatic systems using a combination of vegfr-3 and pd-1 or pd-l1 inhibitors |
WO2019114839A1 (zh) | 2017-12-15 | 2019-06-20 | 泰伦基国际有限公司 | 一种预防或治疗骨关节炎的方法和药物 |
TWI763960B (zh) * | 2017-12-15 | 2022-05-11 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種預防或治療骨關節炎的方法及藥物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
US5945403A (en) | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
US5837682A (en) * | 1996-03-08 | 1998-11-17 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
HU224827B1 (hu) * | 1996-05-03 | 2006-02-28 | Abbott Lab | Új antiangiogén peptidek, azokat kódoló polinukleotidok, és eljárások angiogenezis gátlására |
US5801146A (en) * | 1996-05-03 | 1998-09-01 | Abbott Laboratories | Compound and method for inhibiting angiogenesis |
DE69907139T2 (de) | 1998-01-12 | 2004-01-29 | Searle & Co | Verfahren zur angiostatinrückfaltung |
-
1999
- 1999-07-07 JP JP2000559860A patent/JP2002520367A/ja not_active Withdrawn
- 1999-07-07 EP EP99933721A patent/EP1096945A4/en not_active Withdrawn
- 1999-07-07 WO PCT/US1999/015271 patent/WO2000003726A1/en active IP Right Grant
- 1999-07-07 CA CA002337231A patent/CA2337231A1/en not_active Abandoned
- 1999-07-07 US US09/348,953 patent/US6538103B1/en not_active Expired - Lifetime
- 1999-07-07 AU AU49718/99A patent/AU751283B2/en not_active Ceased
- 1999-07-07 IL IL14072999A patent/IL140729A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000003726A1 (en) | 2000-01-27 |
JP2002520367A (ja) | 2002-07-09 |
US6538103B1 (en) | 2003-03-25 |
AU751283B2 (en) | 2002-08-08 |
AU4971899A (en) | 2000-02-07 |
EP1096945A4 (en) | 2003-01-02 |
CA2337231A1 (en) | 2000-01-27 |
EP1096945A1 (en) | 2001-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL140729A0 (en) | Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof | |
IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
HUP0001539A3 (en) | 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same | |
HUP0103511A3 (en) | Oxazole compounds and pharmaceutical compositions containing them and process for preparation the compounds | |
IL136938A0 (en) | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
HUP0004400A3 (en) | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
HUP0104718A3 (en) | Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions | |
IL131415A (en) | Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them | |
IL127798A (en) | N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
HUP0301187A3 (en) | Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0003058A3 (en) | Soya extract, process for its preparation and pharmaceutical composition | |
HUP9700328A3 (en) | Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates | |
HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
EG21909A (en) | Cream-based food composition and process for the manufacture thereof | |
HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
IL140897A0 (en) | Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL137494A0 (en) | Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
HUP0100488A3 (en) | Thienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
HK1039122A1 (zh) | 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物 | |
HUP0104985A3 (en) | Pharmaceutical levothyroxine compositions and process for their preparation |